Please Wait.....
Report
United States Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 75 Pages I Mordor Intelligence
United States Cardiovascular Devices Market Analysis
The United States cardiovascular devices market size was USD 23.33 billion in 2025 and is on track to reach USD 33.27 billion in 2030, expanding at a 7.36% CAGR during 2025-2030. Growth stems from rising cardiovascular disease prevalence-affecting 126.9 million adults-and steady procedure volumes that stimulate recurring device demand. Artificial-intelligence-enabled diagnostics, transcatheter therapeutic breakthroughs, and payment reforms that reward cost-saving technologies are reshaping competitive priorities. Providers increasingly bundle diagnostic and interventional tools to secure volume-based discounts, subtly shifting bargaining power toward large health systems. Venture-capital inflows, particularly in structural-heart start-ups, expand the innovation pipeline even as hospital capital constraints intensify.
United States Cardiovascular Devices Market Trends and Insights
Obesity-linked PAD surge driving use of drug-coated balloons
Peripheral artery disease now affects 10 million Americans, with 2 million facing critical limb-threatening ischemia. Trial evidence showing a 51.3% fall in target-lesion failure after sirolimus delivery is accelerating hospital adoption of drug-coated balloons, especially for below-the-knee work. Hospitals in high-obesity Southern states are restocking coated balloons, while large systems negotiate multiprocedure discounts that lower per-unit pricing. Device makers respond by adding smaller diameters and extended coating life to suit infrapopliteal anatomy. Payers increasingly cover these balloons once registry data confirm reduced repeat interventions, reinforcing uptake momentum.
ACC/AHA reimbursement revisions incentivizing CRT-D upgrades
The 2025 criteria broaden access to cardiac resynchronization therapy defibrillators and reward extended battery life, yielding USD 15,120 in Medicare savings per patient over six years. Hospitals are pre-ordering premium CRT-D models to capture both clinical benefit and cost share. Early claims data reveal a 17% year-on-year jump in elective generator replacements as providers expedite swaps before older devices reach elective-replacement indicators. Manufacturers highlight remote-monitoring firmware that dovetails with home-care expansion, strengthening the therapy's economic case.
Venture-capital influx into percutaneous mitral repair start-ups
Capstan Medical's USD 110 million Series C epitomizes investor faith in mitral and tricuspid valves, a field where half of severe mitral-regurgitation patients still lack surgery. Venture backing lets entrants lock in premium component pricing and run longer trials, positioning them as attractive acquisition targets. Structural-heart majors now allocate dedicated scouting teams to incubators, intensifying competition for intellectual property. Hospitals anticipate broader device menus that can tailor therapy to anatomy and comorbidity, potentially lifting procedure counts.
Other drivers and restraints analyzed in the detailed report include:
Growth of office-based & ASC cath-labs via CMS site-of-service differential / Hospital capital budget freezes after Medicare rate cuts / Stringent regulatory requirements and product recalls /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutic & surgical products captured 77.20% of United States cardiovascular devices market share in 2024, underpinned by stents, valve implants, and rhythm-management devices that anchor high-value procedures. Drug-eluting stents remain mainstay, yet bioresorbable options and intravascular lithotripsy catheters-now under Johnson & Johnson-offer added revenue streams. Physicians value single-vendor kits that bundle guidewires and imaging catheters, a tactic that deepens wallet share for integrated suppliers.
Diagnostic & monitoring devices are forecast to clock an 8.56% CAGR to 2030, the fastest of any category. Cloud analytics such as EchoGo Amyloidosis, which posts 84.5% sensitivity and 89.7% specificity, convert ultrasound systems into subscription revenue. Growing reliance on remote physiologic monitoring pushes device makers to embed cellular radios, shifting BOM cost to connectivity chips while opening service-fee income.
The United States Cardiovascular Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices [ECG Systems, Remote Cardiac Monitor, and More], Therapeutic & Surgical Devices [Coronary Stents, Catheters, Cardiac Rhythm Management, Heart Valves, Ventricular Assist Devices, and More]), Indication (Coronary Artery Disease, Arrhythmia, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Medtronic / Abbott Laboratories / Boston Scientific / Edward Lifesciences / Johnson&Johnson / Terumo / Beckton Dickinson / W. L. Gore & Associates / Siemens Healthineers / MicroPort CRM (MicroPort Scientific) / BIOTRONIK / LivaNova / Getinge / Teleflex / Cordis / Merit Medical Systems /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Obesity-Linked PAD Surge Driving Use of Drug-Coated Balloons
4.2.2 ACC/AHA Reimbursement Revisions Incentivizing CRT-D Upgrades
4.2.3 Growth of Office-Based & ASC Cath-Labs via CMS Site-of-Service Differential
4.2.4 Venture Capital Influx into Percutaneous Mitral Repair Start-ups
4.2.5 Rapid Adoption of TAVR Post-FDA Low-Risk Approval & Expanded CMS Coverage
4.2.6 Infection-Control Policies Boosting Demand for Single-Use Diagnostic Catheters
4.3 Market Restraints
4.3.1 Hospital Capital Budget Freezes After Medicare Rate Cuts
4.3.2 Stringent regulatory requirements and product recall
4.3.3 Semiconductor Shortages Disrupting ICD Generator Supply
4.3.4 Stringent 510(k) Predicate Requirements for Bioresorbable Scaffolds
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Device
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 ECG Systems
5.1.1.2 Remote Cardiac Monitor
5.1.1.3 Cardiac MRI
5.1.1.4 Cardiac CT
5.1.1.5 Echocardiography / Ultrasound
5.1.1.6 Fractional Flow Reserve (FFR) Systems
5.1.2 Therapeutic & Surgical Devices
5.1.2.1 Coronary Stents
5.1.2.1.1 Drug-Eluting Stents
5.1.2.1.2 Bare-Metal Stents
5.1.2.1.3 Bioresorbable Stents
5.1.2.2 Catheters
5.1.2.2.1 PTCA Balloon Catheters
5.1.2.2.2 IVUS/OCT Catheters
5.1.2.3 Cardiac Rhythm Management
5.1.2.3.1 Pacemakers
5.1.2.3.2 Implantable Cardioverter Defibrillators
5.1.2.3.3 Cardiac Resynchronization Therapy Devices
5.1.2.4 Heart Valves
5.1.2.4.1 TAVR/TAVI
5.1.2.4.2 Mechanical Valves
5.1.2.4.3 Tissue/Bioprosthetic Valves
5.1.2.5 Ventricular Assist Devices
5.1.2.6 Artificial Hearts
5.1.2.7 Grafts & Patches
5.1.2.8 Other Cardiovascular Surgical Devices
5.2 By Indication
5.2.1 Coronary Artery Disease
5.2.2 Arrhythmia
5.2.3 Heart Failure
5.2.4 Valvular Heart Disease
5.3 By End User
5.3.1 Hospitals
5.3.2 Home care Settings
5.3.3 Others
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
6.3.1 Medtronic plc
6.3.2 Abbott Laboratories
6.3.3 Boston Scientific Corporation
6.3.4 Edwards Lifesciences Corporation
6.3.5 Johnson & Johnson
6.3.6 Terumo Corporation
6.3.7 Becton, Dickinson and Company
6.3.8 W. L. Gore & Associates, Inc.
6.3.9 Siemens Healthineers AG
6.3.10 MicroPort CRM (MicroPort Scientific)
6.3.11 Biotronik
6.3.12 LivaNova PLC
6.3.13 Getinge AB
6.3.14 Teleflex Incorporated
6.3.15 Cordis Corporation
6.3.16 Merit Medical Systems, Inc.
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security